Ardena’s Expertise Helps New Treatment for Parkinson’s Disease

Ghent, Belgium 30 August 2021: Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO),.

The Fight for Air Climb and Other Extraordinary Feats by People With PF

A couple of weeks ago, Bert Maidment and Kevin Olson, both of who have Idiopathic.

Inflatable Neurostimulator for Minimally Invasive Pain Control

Researchers at the University of Cambridge created a spinal stimulation device that can help to.

Glucagon-like Peptide-1 Metabolism is Impacted by Anthocyanins and (-)-epicatechin

Obesity and diabetes are major health problems globally, and extensive work is being done to.

The Last Mile: Overcoming COVID-19 Vaccine Hesitancy

Special thanks to Marc Benjamin, a 20-year veteran in health communications and founder of Face2Face.

The latest science on staying healthy during pregnancy

New research examines prenatal supplements, how eating patterns affect sleep, physical activity while pregnant and.

Relapsed, Refractory Follicular Lymphoma: CAR-T Cell Therapy Shows Promise

Axicabtagene ciloleucel (axi-cel) appears to be both safe and effective for treating relapsed/refractory follicular lymphoma.

Living With PTSD? How to Manage Anxiety and Flashbacks

If you have post-traumatic stress disorder (PTSD), you know how much it can mess with your day-to-day.

Strategic Partnership Announced Between IDBS and Scitara

Biopharmaceutical lifecycle management platform IDBS (Guildford, UK) has announced a strategic partnership with software provider.

DLBCL: Naratuximab Shows Promise Among Patients With Relapsed/Refractory Disease

Among patients with diffuse large B cell lymphoma (DLBCL) and other non-Hodgkin B cell lymphomas.